Oncology Rounds

The latest news and research on cancer care from the Oncology Roundtable.

Catching up with CAR-T: How centers are building out capabilities and struggling to get reimbursed

Deirdre Saulet March 12, 2018

When FDA approved two CAR-T cell therapies last year, it caused a groundswell of excitement across the country—but many questions remain around implementation and reimbursement. Keep reading to learn how one leading cancer center has reorganized its services to improve care for immunotherapy patients and how barriers to CAR-T reimbursement are raising concerns about access.

Read more »

What a colleague's breast health care experience taught us about genetic counseling

by Deirdre Saulet and Ashley Riley February 26, 2018

In a recent conversation with one of our Advisory Board colleagues, we were struck by how pivotal cancer genetic counseling services were in her decision of where to receive her breast health care. Our members frequently ask about the best ways to demonstrate the ROI for this poorly reimbursed service, so we want to share her story and explain how it should change your breast cancer program's strategy.


Read more »

How to help the 20% of cancer patients experiencing PTSD symptoms

by Deirdre Saulet and Soleil Shah February 9, 2018

Mental distress experienced before or after a cancer diagnosis can actually decrease patients' chances of survival. A new study published in Cancer looked at the prevalence of post-traumatic stress disorder (PTSD) among cancer patients. Keep reading to see what they found and how your cancer program can help.

Read more »

5 ways providers need to respond to payers' new patient assistance program approach

by Lindsay Conway January 30, 2018

As drug prices rise, a growing portion of infusion center patients have come to rely on drug manufacturers' patient assistance programs (PAPs). The aim of these programs is to ensure that patients can afford their drugs, regardless of their out-of-pocket cost. While PAPs take many forms, most offset or completely cover patients' copay, coinsurance, or deductible for drugs. 

Read more »

Growing your navigator program? Read this first.

by Deirdre Saulet and Mallory Kirby January 16, 2018

One of the most common requests we receive from cancer program leaders is for evidence on the benefits of navigation. 

To help you evaluate the benefits of navigation or to make the case for navigators at your facility, we've compiled a summary of recent studies on patient navigation and their findings here. The big takeaway is that while most of us in cancer care realize how much it can impact the patient experience, there's not much research that provides strong evidence for navigation—but programs can still learn from the results of studies to date.

Read more »

340B, drug administration packaging, and other changes impacting cancer programs in the HOPPS 2018 Final Rule

by Deirdre Saulet and Kate Wister January 3, 2018

CMS has projected an overall increase in hospital outpatient department (HOPD) payments of 1.4% from 2017. However, a significant reduction in reimbursement of 340B drugs and drug packaging changes have left many oncology programs concerned about their revenues for the 2018 calendar year. Read on to learn more about these changes and other HOPPS updates impacting cancer care.

Read more »

Our top 10 oncology quick reads of 2017

by Deirdre Saulet December 19, 2017

A lot has happened this year. To catch up on some of the biggest cancer-related news stories, we've pulled together our top 10 blogs of 2017.

Read more »

ICYMI: A fight over the future of 340B and big strides in precision medicine

by Deirdre Saulet November 20, 2017

This can be the most wonderful—and most hectic—time of the year, so it's understandable if you've fallen behind in your inbox. To help you keep up, here are the biggest news stories for cancer programs from the past month.

Read more »